Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PRECISION ONCOLOGY

A quick guide for clinical oncology

Nature Cancer volume 2, pages 998–999 (2021)Cite this article

Subjects

Clinical interpretation of cancer genomes for therapy selection and clinical hypothesis generation is an urgent and complex endeavor. A new study brings together a diverse set of data sources to automatically prioritize first- and second-order genomic alterations to provide a meaningful set of interpretations based on a patient’s molecular profile.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: An integrated clinical interpretation framework.

References

  1. Chakravarty, D. & Solit, D. B. Nat. Rev. Genet. 22, 483–501 (2021).

    Article  CAS  Google Scholar 

  2. Reardon, B. et al. Nat. Cancer https://doi.org/10.1038/s43018-021-00243-3 (2021).

  3. Van Allen, E. M. et al. Nat. Med. 20, 682–688 (2014).

    Article  Google Scholar 

  4. Tate, J. G. et al. Nucleic Acids Res. 47, D941–D947 (2019).

    Article  CAS  Google Scholar 

  5. Chang, M. T. et al. Cancer Discov. 8, 174–183 (2018).

    Article  CAS  Google Scholar 

  6. Yang, W. et al. Nucleic Acids Res. 41, D955–D961 (2013).

    Article  CAS  Google Scholar 

  7. Ghandi, M. et al. Nature 569, 503–508 (2019).

    Article  CAS  Google Scholar 

  8. Sicklick, J. K. et al. Nat. Med. 25, 744–750 (2019).

    Article  CAS  Google Scholar 

  9. Tamborero, D. et al. Genome Med. 10, 25 (2018).

    Article  Google Scholar 

  10. Chakravarty, D. et al. JCOPrecis. Oncol. 2017, PO.17.00011 (2017).

    Google Scholar 

  11. Griffith, M, et et al. Nat. Genet. 49, 170–174 (2017).

    Article  Google Scholar 

  12. Huang, L. et al. J. Am. Med. Inform. Assoc. 24, 513–519 (2017).

    Article  Google Scholar 

  13. Wagner, A. H. et al. Nat. Genet. 52, 448–457 (2020).

    Article  CAS  Google Scholar 

  14. Ritter, D. I. et al. Genome Med. 8, 117 (2016).

    Article  Google Scholar 

  15. Bielski, C. M. et al. Cancer Cell 34, 852–862.e4 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Ahmet Zehir & Michael F. Berger

  2. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Michael F. Berger

Authors
  1. Ahmet Zehir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael F. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ahmet Zehir or Michael F. Berger.

Ethics declarations

Competing interests

Michael Berger discloses consulting fees from Eli Lilly and PetDx, unrelated to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zehir, A., Berger, M.F. A quick guide for clinical oncology. Nat Cancer 2, 998–999 (2021). https://doi.org/10.1038/s43018-021-00273-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-021-00273-x

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer